Chad E. Mire

Best Publications

• Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates

  Emily P. Thi;Chad E. Mire;Amy C. H. Lee;Joan B. Geisbert

  253
  Citations

• Mutual Antagonism between the Ebola Virus VP35 Protein and the RIG-I Activator PACT Determines Infection Outcome

  Priya Luthra;Parameshwaran Ramanan;Parameshwaran Ramanan;Chad E. Mire;Carla Weisend

  205
  Citations

• Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody Therapy.

  Chad E. Mire;Benjamin A. Satterfield;Joan B. Geisbert;Krystle N. Agans

  202
  Citations

• Therapeutic Treatment of Nipah Virus Infection in Nonhuman Primates with a Neutralizing Human Monoclonal Antibody

  Thomas W. Geisbert;Chad E. Mire;Joan B. Geisbert;Yee Peng Chan

  199
  Citations

• The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses

  Eve Isabelle Pécheur;Viktoriya Borisevich;Peter Halfmann;John D. Morrey

  179
  Citations

• A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses.

  David Safronetz;Chad Mire;Kyle Rosenke;Friederike Feldmann

  167
  Citations

• Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever

  Chad E Mire;Robert W Cross;Joan B Geisbert;Viktoriya Borisevich

  153
  Citations

• The Marburg Virus VP24 Protein Interacts with Keap1 to Activate the Cytoprotective Antioxidant Response Pathway.

  Megan R. Edwards;Britney Johnson;Chad E. Mire;Wei Xu

  131
  Citations

• Post-exposure treatments for Ebola and Marburg virus infections

  Robert W. Cross;Chad E. Mire;Heinz Feldmann;Thomas W. Geisbert

  130
  Citations

• Lead Precipitation by Vibrio harveyi: Evidence for Novel Quorum-Sensing Interactions

  Chad E. Mire;Jeanette A. Tourjee;William F. O'Brien;William F. O'Brien;Kandalam V. Ramanujachary

  128
  Citations

• The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus.

  Luke D. Jasenosky;Cristhian Cadena;Chad E. Mire;Viktoriya Borisevich

  126
  Citations

• Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus

  Chad E. Mire;Demetrius Matassov;Joan B. Geisbert;Theresa E. Latham

  118
  Citations

• The immunomodulating V and W proteins of Nipah virus determine disease course.

  Benjamin A. Satterfield;Robert W. Cross;Karla A. Fenton;Krystle N. Agans

  112
  Citations

• An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections

  Ha V. Dang;Yee Peng Chan;Young Jun Park;Joost Snijder;Joost Snijder

  111
  Citations

• A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates

  Benoit Callendret;Jort Vellinga;Kerstin Wunderlich;Ariane Rodriguez

  110
  Citations

• A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates

  Zachary A. Bornholdt;Andrew S. Herbert;Chad E. Mire;Shihua He

  107
  Citations

• The Domestic Ferret (Mustela putorius furo) as a Lethal Infection Model for 3 Species of Ebolavirus.

  Robert W. Cross;Chad E. Mire;Viktoriya Borisevich;Joan B. Geisbert

  102
  Citations

• Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody

  Chad E. Mire;Joan B. Geisbert;Viktoriya Borisevich;Karla A. Fenton

  101
  Citations

• Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA

  Emily P. Thi;Chad E. Mire;Raul Ursic-Bedoya;Joan B. Geisbert

  96
  Citations

• Differential regulation of interferon responses by Ebola and Marburg virus VP35 proteins

  Megan R. Edwards;Megan R. Edwards;Gai Liu;Chad E. Mire;Suhas Sureshchandra

  96
  Citations